GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (NAS:PRQR) » Definitions » Accumulated other comprehensive income (loss)

ProQR Therapeutics NV (ProQR Therapeutics NV) Accumulated other comprehensive income (loss) : $28.33 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is ProQR Therapeutics NV Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. ProQR Therapeutics NV's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was $28.33 Mil.

ProQR Therapeutics NV's quarterly Accumulated other comprehensive income (loss) increased from Jun. 2023 ($1.08 Mil) to Sep. 2023 ($1.37 Mil) and increased from Sep. 2023 ($1.37 Mil) to Dec. 2023 ($28.33 Mil).

ProQR Therapeutics NV's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($34.24 Mil) to Dec. 2022 ($32.06 Mil) and declined from Dec. 2022 ($32.06 Mil) to Dec. 2023 ($28.33 Mil).

ProQR Therapeutics NV Accumulated other comprehensive income (loss) Historical Data

The historical data trend for ProQR Therapeutics NV's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProQR Therapeutics NV Accumulated other comprehensive income (loss) Chart

ProQR Therapeutics NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.56 29.10 34.24 32.06 28.33

ProQR Therapeutics NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.06 - 1.08 1.37 28.33

ProQR Therapeutics NV Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

ProQR Therapeutics NV Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of ProQR Therapeutics NV's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

ProQR Therapeutics NV (ProQR Therapeutics NV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (NAS:PRQR) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
PRLD MNOV CDXC ANIX GMDA NKTX INO IFRX VXRT ABEO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
0PQ:Germany
Address
Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
Website
https://www.proqr.com
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.